500 cells/mLLikelihood of retention reduced with CD4 ≥500 cells/mL.
NigeriaVIH/sidapublié 2020Journal of the International Association of Providers of AIDS CarePubMeddocument de 6 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 45 / 70
500 cells/mLLikelihood of retention reduced with CD4 ≥500 cells/mL.
NigeriaVIH/sidapublié 2020Journal of the International Association of Providers of AIDS CarePubMeddocument de 6 observations
2,54 odds_ratioAmong HIV-positive individuals, APOL1 polymorphisms in the recessive model were associated with increased risk of prevalent chronic kidney disease, with an adjusted odds ratio of 2.54.
Nigeriamaladie rénale chronique · VIH/sidapublié 2020American journal of kidney diseases : the official journal of the National Kidney FoundatiPubMeddocument de 7 observations
17,2 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 17.2% ever used timed unprotected intercourse without pre-exposure prophylaxis (PrEP) as a safer conception method.
NigeriaVIH/sidapublié 2019International journal of health policy and managementPubMeddocument de 10 observations
0,79 aORAdolescents and young adults in the 'consent and proximity' class were less likely to report condom use (adjusted odds ratio 0.79, 95% confidence interval 0.63–0.99).
NigeriaVIH/sidaobservé 2018publié 2024PloS onePubMeddocument de 15 observations
4,1 timesThe likelihood of HIV-negative pregnant women at term repeating an HIV test was approximately 4.1 times higher when referred by TBAs in cluster 1 compared to those in the control group.
NigeriaVIH/sidapublié 2024BMC pregnancy and childbirthPubMeddocument de 8 observations
30 %Retention-in-care rates among 5107 women ranged from 30% to 76% in the complete dataset.
NigeriaVIH/sidaobservé 2013–2017publié 2020Journal of the International AIDS SocietyPubMeddocument de 3 observations
1,677 AORParticipants who were virally suppressed had a higher likelihood of favorable TB treatment outcome compared to those who were virally unsuppressed (adjusted odds ratio = 1.677, 95% confidence interval = 1.036–2.716).
Nigeriatuberculose · VIH/sidapublié 2024The Pan African medical journalPubMeddocument de 5 observations
0,5 %In 2019, the HIV positivity rate among screened pregnant women in Nigeria was 0.5%.
NigeriaVIH/sidaobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations
1 900 000 peopleNigeria is home to approximately 1.9 million people living with HIV (PLHIV).
NigeriaVIH/sidapublié 2025PloS onePubMed
25,7 %Among 346 participants with complete data, 25.7% showed virological failure with preserved immunity.
NigeriaVIH/sidaobservé 2019–2021publié 2026Frontiers in public healthPubMeddocument de 7 observations
14,4 score_on_4_to_20_scaleThe overall mean score on the HRQOL level of independence domain was 14.4 on a scale of 4–20.
NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 11 observations
27 %Twenty-seven percent of participants were people with HIV.
NigeriaVIH/sidapublié 2024Journal of the International AIDS SocietyPubMeddocument de 9 observations
96 %Viral load testing uptake for HIV improved from 96% to 99% post-transition.
NigeriaVIH/sidapublié 2025BMC health services researchPubMeddocument de 9 observations
-0,1 Z-scoreThe mean BMI Z-score of age-matched HIV-negative controls was -0.10 ± 0.86.
NigeriaVIH/sidapublié 2022BMC pediatricsPubMeddocument de 6 observations
90,5 %The Problem List had sensitivity range 90.5%–85.7% and specificity range 68.3%–65.2% for detecting distress, anxiety, and depression in ART-naïve HIV infected patients, as measured by HADS.
NigeriaVIH/sidapublié 2019African health sciencesPubMeddocument de 2 observations
33,8 %33.8% of patients with HIV had intestinal parasites co-infections.
Nigeriaintestinal parasites · VIH/sidapublié 2011Acta tropicaeurope_pmcdocument de 5 observations
97 %The probability of partners of married respondents being aware of their spouse's HIV serostatus was 97%.
NigeriaVIH/sidapublié 2022Journal of biosocial sciencePubMeddocument de 8 observations
30 fold_increaseThe risk of psychological distress increased 30-fold in the first year on therapy in people with HIV in Nigeria.
NigeriaVIH/sidaobservé first yearpublié 2023International journal of behavioral medicinePubMeddocument de 7 observations
61 %Among 1,598 people living with HIV (PLHIV) on antiretroviral therapy (ART) in three states in southern Nigeria surveyed between July and August 2019, 61.0% were willing to pay for viral load testing services.
NigeriaVIH/sidaobservé July and August 2019publié 2023PloS onePubMeddocument de 9 observations
377 people377 (69.7%) of the people living with HIV who refused linkage to treatment eventually accepted treatment using an alternative community treatment method.
NigeriaVIH/sidapublié 2019International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 6 observations
0,8 %Moderately reduced eGFR was observed in 0.8% of the participants in a cohort of 121 HIV-infected children on HAART.
Nigeriakidney disease · VIH/sidapublié 2025African health sciencesPubMeddocument de 7 observations
6 %Previously married females accounted for 6% of the estimated new HIV infections in Lagos state.
NigeriaVIH/sidapublié 2024Journal of the International Association of Providers of AIDS CarePubMeddocument de 7 observations
Glutathione (GSH) and glutathione peroxidase (GPX) were significantly reduced in HIV infection.
NigeriaVIH/sidapublié 2019BMC infectious diseasesPubMeddocument de 7 observations
45,4 %45.4% of respondents reported storing their medicines in a concealed location within their residence.
NigeriaVIH/sidapublié 2025BMC public healthPubMeddocument de 6 observations
13,3 aORAmong HIV-positive participants in the TRUST/RV368 cohort, having 200 or less CD4 cells/mm³ was associated with highly similar anal HPV genotypes at 12 months (adjusted odds ratio 13.3, 95% CI 2.7–65.2).
Nigeriainfection à HPV · VIH/sidapublié 2022Sexually transmitted diseasesPubMeddocument de 13 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.